A/MSM/2/2 Report of the Steering Committee of the Member State mechanism on
substandard/spurious/ falsely-labelled/falsified/counterfeit medical products,
including the draft workplan as proposed by the Steering Committee
A/MSM/2/3 Report of the Open-ended Working Group to Identify the Actions, Activities and
Behaviours that Result in Substandard/Spurious/Falselylabelled/
Falsified/Counterfeit Medical Product
A/MSM/2/4 Budget and cost implications and implementation of the workplan, and the outcome
of the Open-ended Working Group to Identify the Actions, Activities and
Behaviours that Result in
Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit Medical Products,
including time frames
